Anti-NR3C1 monoclonal antibody

Pre-made anti-NR3C1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to NR3C1/NR3C1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T40016-Ab-1/ GM-Tg-hg-T40016-Ab-2Anti-Human NR3C1 monoclonal antibodyHuman
GM-Tg-rg-T40016-Ab-1/ GM-Tg-rg-T40016-Ab-2Anti-Rat NR3C1 monoclonal antibodyRat
GM-Tg-mg-T40016-Ab-1/ GM-Tg-mg-T40016-Ab-2Anti-Mouse NR3C1 monoclonal antibodyMouse
GM-Tg-cynog-T40016-Ab-1/ GM-Tg-cynog-T40016-Ab-2Anti-Cynomolgus/ Rhesus macaque NR3C1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T40016-Ab-1/ GM-Tg-felg-T40016-Ab-2Anti-Feline NR3C1 monoclonal antibodyFeline
GM-Tg-cang-T40016-Ab-1/ GM-Tg-cang-T40016-Ab-2Anti-Canine NR3C1 monoclonal antibodyCanine
GM-Tg-bovg-T40016-Ab-1/ GM-Tg-bovg-T40016-Ab-2Anti-Bovine NR3C1 monoclonal antibodyBovine
GM-Tg-equg-T40016-Ab-1/ GM-Tg-equg-T40016-Ab-2Anti-Equine NR3C1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T40016-Ab-1/ GM-Tg-hg-T40016-Ab-2; GM-Tg-rg-T40016-Ab-1/ GM-Tg-rg-T40016-Ab-2;
GM-Tg-mg-T40016-Ab-1/ GM-Tg-mg-T40016-Ab-2; GM-Tg-cynog-T40016-Ab-1/ GM-Tg-cynog-T40016-Ab-2;
GM-Tg-felg-T40016-Ab-1/ GM-Tg-felg-T40016-Ab-2; GM-Tg-cang-T40016-Ab-1/ GM-Tg-cang-T40016-Ab-2;
GM-Tg-bovg-T40016-Ab-1/ GM-Tg-bovg-T40016-Ab-2; GM-Tg-equg-T40016-Ab-1/ GM-Tg-equg-T40016-Ab-2
Products NameAnti-NR3C1 monoclonal antibody
Formatmab
Target NameNR3C1
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-NR3C1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    BiosimilarGMP-Bios-ab-627Pre-Made Volagidemab biosimilar, Whole mAb, Anti-GCCR/NR3C1 Antibody: Anti-GCR/GCRST/GR/GRL therapeutic antibody
    Target AntigenGM-Tg-g-T40016-Ag-1Recombinant multi-species GCR/ NR3C1/ GCCR protein
    ORF Viral VectorpGMAAV000039mouse Nr3c1 AAV plasmid
    ORF Viral VectorpGMAAV000177house mouse Nr3c1 AAV plasmid
    ORF Viral VectorvGMAAV000039mouse Nr3c1 AAV particle
    ORF Viral VectorvGMAAV000177house mouse Nr3c1 AAV particle


    Target information

    Target IDGM-T40016
    Target NameNR3C1
    Gene ID2908,14815,24413,706198,478047,101080939,281946,100061217
    Gene Symbol and SynonymsGCCR,GCL,GCR,GCRST,GR,GR-A,GRL,Grl-1,Grl1,NR3C1
    Uniprot AccessionP04150,P06536
    Uniprot Entry NameGCR_HUMAN,GCR_RAT
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target, Immuno-oncology Target, INN Index
    DiseaseCancer
    Gene EnsemblENSG00000113580
    Target ClassificationCheckpoint-Immuno Oncology, Nuclear Receptors, Tumor-associated antigen (TAA)

    The target: NR3C1, gene name: NR3C1, also named as GCCR, GCR, GCRST, GR, GRL. This gene encodes glucocorticoid receptor, which can function both as a transcription factor that binds to glucocorticoid response elements in the promoters of glucocorticoid responsive genes to activate their transcription, and as a regulator of other transcription factors. This receptor is typically found in the cytoplasm, but upon ligand binding, is transported into the nucleus. It is involved in inflammatory responses, cellular proliferation, and differentiation in target tissues. Mutations in this gene are associated with generalized glucocorticoid resistance. Alternative splicing of this gene results in transcript variants encoding either the same or different isoforms. Additional isoforms resulting from the use of alternate in-frame translation initiation sites have also been described, and shown to be functional, displaying diverse cytoplasm-to-nucleus trafficking patterns and distinct transcriptional activities (PMID:15866175). [provided by RefSeq, Feb 2011].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.